Literature DB >> 27663910

Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon.

Ahmad Al Atrouni1, Monzer Hamze2, Tamima Jisr3, Carole Lemarié4, Matthieu Eveillard5, Marie-Laure Joly-Guillou5, Marie Kempf6.   

Abstract

OBJECTIVES: To investigate the molecular epidemiology of Acinetobacter baumannii strains isolated from different hospitals in Lebanon.
METHODS: A total of 119 non-duplicate Acinetobacter strains were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and partial rpoB gene sequencing. Antibiotic susceptibility testing was performed by disc diffusion method and all identified carbapenem-resistant isolates were investigated by PCR assays for the presence of the carbapenemase-encoding genes. Multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) were used for molecular typing.
RESULTS: Of the 119 A. baumannii isolates, 76.5% were resistant to carbapenems. The most common carbapenemase was the OXA-23-type, found in 82 isolates. The study of population structure using MLST revealed the presence of 30 sequence types (STs) including 18 new ones, with ST2 being the most commonly detected, accounting for 61% of the isolates typed. PFGE performed on all strains of ST2 identified a major cluster of 53 isolates, in addition to three other minor clusters and ten unique profiles.
CONCLUSIONS: This study highlights the wide dissemination of highly related OXA-23-producing carbapenem-resistant A. baumannii belonging to the international clone II in Lebanon. Thus, appropriate infection control measures are recommended in order to control the geographical spread of this clone in this country.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acinetobacter baumannii; Carbapenem resistance; Clonal complex II; Lebanon; OXA-23

Mesh:

Substances:

Year:  2016        PMID: 27663910     DOI: 10.1016/j.ijid.2016.09.017

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  22 in total

1.  Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico.

Authors:  Roberto Rosales-Reyes; Catalina Gayosso-Vázquez; José Luis Fernández-Vázquez; Ma Dolores Jarillo-Quijada; César Rivera-Benítez; José Ignacio Santos-Preciado; María Dolores Alcántar-Curiel
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

2.  In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques.

Authors:  Micheline A H Soudeiha; Elias A Dahdouh; Eid Azar; Dolla K Sarkis; Ziad Daoud
Journal:  Front Cell Infect Microbiol       Date:  2017-05-24       Impact factor: 5.293

Review 3.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

4.  The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates.

Authors:  Bojana Lukovic; Ina Gajic; Ivica Dimkic; Dusan Kekic; Sanja Zornic; Tatjana Pozder; Svetlana Radisavljevic; Nataša Opavski; Milan Kojic; Lazar Ranin
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-06       Impact factor: 4.887

5.  Seasonal Occurrence and Carbapenem Susceptibility of Bovine Acinetobacter baumannii in Germany.

Authors:  Peter Klotz; Paul G Higgins; Andreas R Schaubmar; Klaus Failing; Ursula Leidner; Harald Seifert; Sandra Scheufen; Torsten Semmler; Christa Ewers
Journal:  Front Microbiol       Date:  2019-02-22       Impact factor: 5.640

6.  Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon.

Authors:  Tania Nawfal Dagher; Charbel Al-Bayssari; Selma Chabou; Nadine Antar; Seydina M Diene; Eid Azar; Jean-Marc Rolain
Journal:  BMC Microbiol       Date:  2019-02-02       Impact factor: 3.605

7.  Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania.

Authors:  Happiness H Kumburu; Tolbert Sonda; Marco van Zwetselaar; Pimlapas Leekitcharoenphon; Oksana Lukjancenko; Blandina T Mmbaga; Michael Alifrangis; Ole Lund; Frank M Aarestrup; Gibson S Kibiki
Journal:  J Antimicrob Chemother       Date:  2019-06-01       Impact factor: 5.790

8.  A compilation of antimicrobial susceptibility data from a network of 13 Lebanese hospitals reflecting the national situation during 2015-2016.

Authors:  Rima Moghnieh; Georges F Araj; Lyn Awad; Ziad Daoud; Jacques E Mokhbat; Tamima Jisr; Dania Abdallah; Nadim Azar; Noha Irani-Hakimeh; Maher M Balkis; Mona Youssef; Gilbert Karayakoupoglou; Monzer Hamze; Madonna Matar; Roula Atoui; Edmond Abboud; Rita Feghali; Nadine Yared; Rola Husni
Journal:  Antimicrob Resist Infect Control       Date:  2019-02-20       Impact factor: 4.887

Review 9.  Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Ilda Barbu Czobor; Mariana Carmen Chifiriuc
Journal:  Microorganisms       Date:  2020-06-21

10.  A multiplex loop-mediated isothermal amplification assay for rapid screening of Acinetobacter baumannii and D carbapenemase OXA-23 gene.

Authors:  Rungong Yang; Honghong Zhang; Xiaoxia Li; Ling Ye; Meiliang Gong; Jinghui Yang; Jihong Yu; Jie Bai
Journal:  Biosci Rep       Date:  2018-09-07       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.